Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

NCT00712504 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Non Small Cell Lung Cancer

Interventions

DRUG: sunitinib
DRUG: docetaxel

Sponsor

Pfizer